Trial
NCT01927055
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Phase IIITERMINATEDREGULATORYConfidence: HIGH
Sponsor
Chelsea Therapeutics
Collaborators
—
Condition
Symptomatic Neurogenic Orthostatic Hypotension
Intervention
Droxidopa
Why stopped
Due to potential competition with a post-marketing study requested by FDA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-08